3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Withdrawn
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
12
Head & Neck
12
Tumor-Agnostic
9
Gynecologic
8
Genitourinary
8
Gastrointestinal
7
Dermatologic
6
Sarcoma
4
CNS
3
Other solid neoplasm
2
Plasma cell
1
NET
1
Myeloid
1
Endocrine
1
Conditions
Myelodysplastic Syndromes
100
Leukemia, Myeloid, Acute
79
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
Myeloproliferative Disorders
40
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
37
Leukemia, Myelomonocytic, Chronic
32
Primary Myelofibrosis
30
Lymphoma, Non-Hodgkin
30
Polycythemia Vera
19
Lymphoma
15
Leukemia
15
Hematologic Neoplasms
15
Leukemia, Biphenotypic, Acute
14
Thrombocythemia, Essential
13
Multiple Myeloma
11
Hodgkin Disease
11
Histiocytosis, Langerhans-Cell
11
Neoplasms
10
Leukemia, Myeloid, Chronic-Phase
10
Leukemia, Lymphocytic, Chronic, B-Cell
10
Rhabdoid Tumor
9
Neuroblastoma
9
Medulloblastoma
9
Glioma
9
Ependymoma
9
Anemia, Refractory, with Excess of Blasts
9
Wilms Tumor
8
Sarcoma
8
Rhabdomyosarcoma
8
Osteosarcoma
8
Interventions
etoposide phosphate
1
Sirolimus
1
Etoposide
1
Cyclophosphamide
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Carcinoma
×
Myeloid
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled